Although the CDK inhibitory functions of p16INK4a are well described, the mechanisms underlying p16INK4a-mediated senescence are poorly understood and the relative contribution of p16INK4a-induced senescence to its role as a tumour suppressor has not been addressed. The gene discussed is CDKN2A; the disease is neoplasm.